
Active Pharmaceutical Ingredients List
Discover our range of high-quality Active Pharmaceutical Ingredients (APIs), carefully listed for easy reference. Each ingredient supports effective and reliable healthcare solutions across various treatments.
No. | Case | Product Name |
---|---|---|
1 | 5717-37-3 | Sacubitril/Valsartan intermediates |
2 | 1426129-50-1 | Sacubitril/Valsartan intermediates |
3 | 1012341-48-8 | Sacubitril intermediates |
4 | 1012341-50-2 | Sacubitril intermediates (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
5 | 149690-12-0 | Sacubitril intermediates(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate hydrochloride |
6 | 1369773-39-6 | Sacubitrial Calcium |
7 | 936623-90-4 | Sacubitril/Valsartan LCZ API |
No. | Case | Product Name |
---|---|---|
1 | 4318-56-3 | Alogliptin intermediate 3-Methyl-6-Chlorouracil |
2 | 865758-96-9 | Alogliptin intermediate 2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile |
3 | 850649-61-5 | Alogliptin Base |
4 | 850649-62-6 | Alogliptin Benzoate API |
5 | 334618-23-4 | Alogliptin intermediate (R)-3-Piperidinamine dihydrochloride |
6 | 22115-41-9 | Alogliptin intermediate 2-Cyanobenzyl bromide |
7 | 421552-12-7 | Trelagliptin intermediate 2-Bromomethyl-4-fluoro benzonitrile |
8 | 865759-24-6 | Trelagliptin intermediate 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-4-fluoro-benzonitrile |
9 | 865759-25-7 | Trelagliptin intermediate 2-[6-(3-Amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]- |
10 | 1029877-94-8 | Trelagliptin succinate API |
11 | 1076-22-8 | Linagliptin intermediate 3-Methylxanthine( india site) |
12 | 93703-24-3 | Linagliptin intermediate 3-Methyl-8-bromoxanthine(india site ) |
13 | 666816-98-4 | Linagliptin intermediate 8-bromo-7-but-2-yn-1-yl-3-methyl-3,7-dihydro-1H-purine-2,6-dione |
14 | 109113-72-6 | Linagliptin intermediate Quinazoline, 2-(chloromethyl)-4-methyl15 853029-57-9 Linagliptin intermediate 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine |
16 | 668270-12-0 | Linagliptin API |
17 | 309956-78-3 | Linagliptin intermediate (R)-(+)-3-tert-Butoxycarbonylaminopiperidine |
18 | 461432-25-7 | Dapagliflozin N-1 |
19 | 960404-48-2 | Dapagliflozin API |
20 | 915095-89-5 | Empagliflozin intermediates |
21 | 864070-44-0 | Empagliflozin API |
22 | 915095-99-7 | Empagliflozin N-1 |
23 | 654671-77-9 | Sitagliptin Phosphate Monohydrate |
24 | 654671-78-0 | Sitagliptin Phosphate |
25 | 486460-32-6 | Sitagliptin BASE |
No. | Case | Product Name |
---|---|---|
1 | 412003-95-3 | Lemborexant intermediates 1 5-Pyrimidinol, 2,4-dimethyl- (9CI) |
2 | 1450904-92-3 | Lemborexant intermediates 2 |
3 | 1369764-02-2 | Lemborexant API |
4 | 19608-29-8 | Clascoterone API |
5 | 152-58-9 | Cortexolone Clascoterone Intermediate |
6 | 104966-97-4 | idebenone intermediates 6-(10-hydroxydecanoyl)-2,3-dimethoxy-5-methylphenol |
7 | 1050477-31-0 | Finerenone API |
8 | 95306-64-2 | Finerenone intermediate |
9 | 65193-87-5 | Finerenone intermediate |
10 | 532-12-7 | Nicotine Intermediates MYOSMINE |
11 | 107575-60-0 | Nicotine Intermediates Ethyl 6-amino-5-methoxyindole-2-carboxylate |
12 | 30123-17-2 | Tianeptine sodium salt |
13 | 64228-81-5 | Atracurium besilate API |
14 | 1256269-87-0 | SAK-3 |
15 | 1197953-49-3 | AP26113 intermediates 1 |
16 | 2296729-00-3 | Sotorasib AMG510 |
No. | Case | Product Name |
---|---|---|
1 | 379270-35-6 | Tenofovir Alafenamide Fumarate N-3 |
2 | 379270-37-8 | Tenofovir Alafenamide N-2 |
3 | 1392275-56-7 | Tenofovir Alafenamide Fumarate API |
4 | 1985606-14-1 | Baloxavir marboxil API |
5 | 1985605-59-1 | Baloxavir |
6 | 1985607-70-2 | Baloxavir marboxil Intermediates |
7 | 2346620-55-9 | Molnupiravir N-1 |
8 | 2349386-89-4 | Molnupiravir API |
9 | 666832-71-9 | Paxlovid intermediates L-Valine,3-methyl-N-(trifluoroacetyl)-(9CI) |
10 | 159326-68-8 | Remdesivir Intermediate 2 PYRROLO[1,2-F][1,2,4]TRIAZIN-4-AMINE |
11 | 55094-52-5 | Remdesivir Intermediate |
12 | 1770840-43-1 | Remdesivir Intermediate 2 4-amino-7-iodopyrrolo[2,1-f][1,2,4]triazine |
13 | 1190307-88-0 | Sofosbuvir |
14 | N/A | velpatasvir PVP |
15 | 1009119-65-6 | Declatasvir |
16 | N/A | Ledipatasvir PVP |
17 | 82956-11-4 | Nafamostat mesylate |
No. | Case | Product Name |
---|---|---|
1 | 122628-50-6 | Pyrroloquinolinequinone disodium salt (PQQ) |
2 | 1094-61-7 | β-Nicotinamide mononucleotide(NMN) |
3 | 23111-00-4 | NR-CL 70% |
4 | 23111-00-4 | NR-CL 98% |
5 | 1352002-58-4 | TPP- Thiazole |
6 | 606-68-8 | NADH |
7 | 305-84-0 | L - carnosine |
8 | 922-32-7 | Creatine phosphate disodium salt |
9 | 282526-98-1 | Cetilistat API |
Tinibs & Anti-Tumor Drug Promote: | ||
1 | 1187594-09-7 | Baricitinib API |
2 | 1187595-90-9 | Baricitinib N-1 |
3 | 1029716-44-6 | Baricitinib intermediate 1 |
4 | 1187595-85-2 | Baricitinib intermediate 2 |
5 | 3680-69-1 | Baricitinib intermediate 3 |
6 | 540737-29-9 | Tofacitinib Citrate API |
7 | 1062580-52-2 | Tofacitinib intermediate 1 |
8 | 90213-66-4 | Tofacitinib intermediate 2 |
9 | 1421373-66-1 | Osimertinib Mesylate API |
10 | 1421373-65-0 | Osimertinib Base |
11 | 1421372-66-8 | Osimertinib N-2 |
12 | 1421372-94-2 | Osimertinib N-3 |
13 | 936563-96-1 | Ibrutinib API |
14 | 1022150-12-4 | Ibrutinib N-1 |
15 | 330786-24-8 | Ibrutinib intermediates |
16 | 143900-44-1 | Ibrutinib intermediates |
17 | 1613220-15-7 | Niraparib monohydrate API |
18 | 1038915-60-4 | Niraparib Base |
19 | 1171197-20-8 | Niraparib intermediates |
20 | 571190-30-2 | Palbociclib API |
21 | 571188-59-5 | Palbociclib Intermediates |
22 | 1016636-76-2 | Palbociclib Intermediates |
23 | 912445-05-7 | Veliparib HCL |
24 | 1197953-54-0 | Brigatinib API |
25 | 1197953-49-3 | Brigatinib N-1 |
26 | 912445-05-7 | Veliparib HCL |
27 | 284461-73-0 | Sorafenib |
28 | 341031-54-7 | Sunitinib Malate |
29 | 912444-00-9 | Veliparib |
30 | 1038915-60-4 | Veliparib Base |
31 | 877399-52-5 | Crizotinib |
32 | 302962-49-8 | Dasatinib monohydrate |
33 | 231277-92-2 | Lapatinib |
34 | 417716-92-8 | Lenavatinib Mesylate |
35 / | 59-05-2 | Methotrexate |
36 | 154229-18-2 | Abirterone Acetate |
37 | 191732-72-6 | Lenalidomide |
38 | 41575-94-4 | Carboplatin |
39 | 15663-27-1 | Cisplatin |
40 | 63121-00-6 | Oxaliplatin |
No. | Case | Product Name |
---|---|---|
1 | 61857-83-8 | 3-ATMA |
2 | 608141-41-9 | Apremilast API |
3 | 708-06-5 | 2-Hydroxy-1-naphthaldehyde |
4 | 2224-00-2 | 2-Ethoxy-1-Naphthoic Acid |
5 | 626-64-2 | 4-Hydroxypyridine |
6 | 2835-77-0 | 2-Aminobenzophenone |
7 | 4584-46-7 | 2-Dimethylaminoethyl chloride Hydrochloride |
8 | 4076-36-2 | 5-Methyl-1H-tertazole |
9 | 14008-48-1 | 2,2-Bis(p-acetoxyphenyl)-2H-1,4-benzoxazin-3(4H)-one |
10 | 103980-44-5 | Ceftiofur hydrochloride |
11 | 104010-37-9 | Ceftiofur sodium |
12 | 97468-37-6 | Cephapirin Benzathine |
13 | 118443-89-3 | Cefquinome Sulfate |
14 | 376608-71-8 | Hydroxy-phenyl-acetate2-(3,4-difluoro-phenyl)-cyclopropyl-ammonium |
15 | 145783-15-9 | Ticagrelor Intermediates4,6-Dichloro-2-propylsulfanyl-pyrimidin-5-ylamine |
16 | 376608-65-0 | Ticagrelor Intermediates 3-Carboxy-2,3-dihydroxy-propionate6-(2-hydroxy-ethoxy)-2,2-dimethyl-tetrahydro-cyclopenta[1,3]dioxol-4- |
17 | 376608-71-8 | Ticagrelor Intermediates Hydroxy-phenyl-acetate2-(3,4-difluoro-phenyl)-cyclopropyl-ammonium |